| ||Format||Pages||Price|| |
|5||$48.00||  ADD TO CART|
|Hardcopy (shipping and handling)||5||$48.00||  ADD TO CART|
|Standard + Redline PDF Bundle||10||$58.00||  ADD TO CART|
Significance and Use
4.1 An analyst should be knowledgeable, through established laboratory training, of clandestine drug laboratory synthetic routes and the techniques used in the analysis of related samples. This acquired knowledge of clandestine drug laboratory samples assists the analyst in choosing the best analytical scheme to identify reagents, precursors, intermediates, and final products.
4.2 The qualitative and quantitative analyses of clandestine drug laboratory evidence can require different approaches relative to routine seized drug analyses. Analysts shall understand the limitations of the procedures used in their qualitative and quantitative analyses. These include such factors as method selectivity, uncertainty, and the basis for inferences from a sample(s) to a population.
4.3 Laboratory management shall ensure that clandestine drug laboratory synthesis and analysis training be provided through relevant procedures, literature, and practical experience. Practical experience typically includes production, sampling and analysis of clandestine drug laboratory training samples.
4.4 Laboratory management shall ensure that chemical safety and hygiene plans address and mitigate hazards associated with clandestine drug laboratory evidence.
4.5 It does not address scene attendance or scene processing.
4.6 Laboratory management shall consider customer/local requirements which influence the application of these recommendations.
1.1 This standard is intended to be used in conjunction with the general requirements for the analysis of seized drugs (Practices , , , and ; Guides and ). This standard provides guidance on the chemical analysis of items and samples related to suspected clandestine drug laboratories. This standard provides general guidance for the analysis of clandestine drug laboratory evidence and is not a substitute for detailed and validated laboratory policies and technical procedures.
1.2 This standard cannot replace knowledge, skills, or abilities acquired through education, training, and experience (see Practice ) and is to be used in conjunction with professional judgment by individuals with such discipline-specific knowledge, skills, and abilities.
1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.4 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
2. Referenced Documents (purchase separately) The documents listed below are referenced within the subject standard but are not provided as part of the standard.
D6161 Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration, and Reverse Osmosis Membrane Processes
E1605 Terminology Relating to Lead in Buildings
E2326 Practice for Education and Training of Seized-Drug Analysts
E2327 Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis
E2329 Practice for Identification of Seized Drugs
E2363 Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry
E2548 Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis
E2549 Practice for Validation of Seized-Drug Analytical Methods
F2725 Guide for European Unions Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange
ICS Number Code 71.040.40 (Chemical analysis)
|Link to Active (This link will always route to the current Active version of the standard.)|
ASTM E2882-19, Standard Guide for Analysis of Clandestine Drug Laboratory Evidence, ASTM International, West Conshohocken, PA, 2019, www.astm.orgBack to Top